Literature DB >> 10442913

Primary combined trabeculotomy-trabeculectomy for early-onset glaucoma in Sturge-Weber syndrome.

A K Mandal1.   

Abstract

OBJECTIVE: To evaluate the safety and efficacy of primary combined trabeculotomy-trabeculectomy in the management of early-onset glaucoma associated with Sturge-Weber syndrome (SWS).
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Ten eyes of nine patients were included in this study. All patients with SWS who underwent primary combined trabeculotomy-trabeculectomy from January 1993 through December 1996 were included. One patient had bilateral surgery. INTERVENTION: Primary combined trabeculotomy-trabeculectomy. MAIN OUTCOME MEASURES: Pre- and postoperative intraocular pressures (IOPs), corneal clarity and diameters, visual acuities, success rate, bleb characteristics, time of surgical failure (if any), and complications.
RESULTS: The mean preoperative IOP was 28.2 mmHg +/- 7.35 mmHg with medication (mean, 1.2 +/- 0.6; range, 0-2). The mean postoperative IOP was 11.8 mmHg +/- 1.8 mmHg, with a mean percent reduction of 55.8 +/- 12.6 in IOP (P < 0.0001). All eyes maintained a postoperative IOP < 16 mmHg without medication over a mean follow-up of 27.6 +/- 16.4 months (range, 12-64 months). Normal corneal clarity was achieved in all eight eyes that had corneal edema. There were no significant intraoperative complications. Postoperatively, one patient developed a shallow anterior chamber with choroidal detachment, which was successfully managed conservatively.
CONCLUSION: Primary combined trabeculotomy-trabeculectomy is safe, effective, and sufficiently predictable to be considered the first choice of surgical treatment in early-onset glaucoma associated with SWS.

Entities:  

Mesh:

Year:  1999        PMID: 10442913     DOI: 10.1016/S0161-6420(99)90462-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

Review 1.  [Glaucoma due to elevated episcleral venous pressure].

Authors:  R Greslechner; I Oberacher-Velten
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

2.  Anomalous vessels over a trabeculectomy bleb in Sturge-Weber syndrome.

Authors:  Aparna Rao; Geetha Srinivasan; Viney Gupta
Journal:  Digit J Ophthalmol       Date:  2011-01-29

Review 3.  Pathophysiology, diagnosis, and management of glaucoma associated with Sturge-Weber syndrome.

Authors:  Usman Javaid; Muhammad Hassaan Ali; Samreen Jamal; Nadeem Hafeez Butt
Journal:  Int Ophthalmol       Date:  2017-01-07       Impact factor: 2.031

4.  Early-onset glaucoma in Axenfeld-Rieger anomaly: long-term surgical results and visual outcome.

Authors:  A K Mandal; N Pehere
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

5.  Vascular tumors of the retina and choroid: diagnosis and treatment.

Authors:  Mary E Turell; Arun D Singh
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

6.  Therapeutic effect analysis on the treatment of congenital glaucoma through modified combined trabeculotomy-trabeculectomy.

Authors:  Zhen-Kai Wu; Jing Wu; Qian Tan; Jian Jiang; Wei-Tao Song; Xiao-Bo Xia
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

7.  Latanoprost in port wine stain related paediatric glaucoma.

Authors:  T Ong; A Chia; K K Nischal
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

8.  Ahmed valve implantation in childhood glaucoma associated with Sturge-Weber syndrome: our experience.

Authors:  Jaya Kaushik; Jitendra Kumar Singh Parihar; Vaibhav Kumar Jain; Vijay Mathur
Journal:  Eye (Lond)       Date:  2018-10-18       Impact factor: 3.775

9.  Primary single-plate Molteno tube implantation for management of glaucoma in children with Sturge-Weber syndrome.

Authors:  Heydar Amini; Mohammad Reza Razeghinejad; Bahare Esfandiarpour
Journal:  Int Ophthalmol       Date:  2007-06-08       Impact factor: 2.029

Review 10.  Ocular manifestations of Sturge-Weber syndrome: pathogenesis, diagnosis, and management.

Authors:  Flavio Mantelli; Alice Bruscolini; Maurizio La Cava; Solmaz Abdolrahimzadeh; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2016-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.